RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Luis M. Vilá to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Luis M. Vilá has written about Dose-Response Relationship, Drug.
Luis M. Vilá
Connection Strength
0.243
Dose-Response Relationship, Drug
  1. Ruiz K, Serrano-Arroyo L, Valent?n-Rosa V, Torres-Borges G, Vil? LM. Long-term outcomes of hydroxychloroquine dose reduction in Puerto Ricans with systemic lupus erythematosus: 6-year follow-up. Lupus Sci Med. 2026 Mar 24; 13(1).
    View in: PubMed
    Score: 0.192
  2. Bertoli AM, Font YM, Nadal A, Vil? LM. Differences between active treatment and placebo groups in the study of induction treatment of giant cell arteritis with high-dose glucocorticoids: comment on the article by Mazlumzadeh et al. Arthritis Rheum. 2007 May; 56(5):1723; author reply 1723-4.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support